An antiarrhythmic drug used in the treatment of tachycardia, atrial fibrillation, and arrhythmias associated with conditions such as Wolff–Parkinson– White syndrome (a congenital abnormality of heart-rhythm). It is given, as tablets or injection, to people resistant to or intolerant of other treatment; and treatment is always initiated in hospital. Side effects may include dizziness, visual disturbances, and worsening, or a new type of, arrhythmia. Rarely, nausea, vomiting, urticaria, vertigo, and jaundice occur.
Flecainide |
|
|